ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Climb Bio Inc

Climb Bio Inc (CLYM)

2.00
0.13
(6.95%)
Closed January 11 3:00PM
2.00
-0.01
(-0.50%)
After Hours: 6:35PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.00
Bid
2.01
Ask
2.23
Volume
1,706,374
1.97 Day's Range 2.2669
1.73 52 Week Range 5.86
Market Cap
Previous Close
1.87
Open
2.00
Last Trade Time
Financial Volume
US$ 3,431,943
VWAP
2.0112
Average Volume (3m)
331,015
Shares Outstanding
67,223,760
Dividend Yield
-
PE Ratio
-9.78
Earnings Per Share (EPS)
-0.52
Revenue
-
Net Profit
-35.12M

About Climb Bio Inc

Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cel... Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Climb Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLYM. The last closing price for Climb Bio was US$1.87. Over the last year, Climb Bio shares have traded in a share price range of US$ 1.73 to US$ 5.86.

Climb Bio currently has 67,223,760 shares outstanding. The market capitalization of Climb Bio is US$125.71 million. Climb Bio has a price to earnings ratio (PE ratio) of -9.78.

CLYM Latest News

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

Transaction Expands Climb Bio’s Pipeline of B-cell Targeted Therapeutics to Address Immune-mediated Diseases New Program is a Highly Potent, Fc-engineered anti-APRIL Monoclonal Antibody...

Climb Bio to be Added to the Nasdaq Biotechnology Index

WELLESLEY HILLS, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) -- December 19, 2024 – Climb Bio, Inc. (Nasdaq: CLYM) today announced that the company will be added to the NASDAQ Biotech Index (Nasdaq:...

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Appointed Douglas Williams, Ph.D. as Chair of the Board of Directors FDA Clearance of Investigational New Drug Application (IND) for systemic lupus erythematosus (SLE) Expanded Management Team...

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

WELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its Board of Directors...

Climb Bio to Present at Upcoming Investor Conferences

WELLESLEY, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that members of its executive team are scheduled to participate in the upcoming investor conferences...

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

Completes Transition to Immune-Mediated Disease Focused Company Highlights Additional Data from Phase 1b Primary Membranous Nephropathy (pMN) Study with plans to Advance to Late Phase Development...

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

WELLESLEY, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that it will present data at the American Society of Nephrology Kidney Week 2024, which will take...

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

WELLESLEY, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced today it will present and host investor meetings at William Blair’s Transforming Autoimmune Diseases...

Climb Bio to Host Virtual Investor Event on October 15, 2024

WELLESLEY, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced today it will host a virtual investor day on October 15, 2024. The event will feature members of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.09-4.306220095692.092.361.872419172.18782505CS
4-0.9-31.03448275862.92.91.734560182.0596687CS
12-2.87-58.9322381934.875.11.733310152.963888CS
26-3.03-60.23856858855.035.861.733371043.35500845CS
52-3.03-60.23856858855.035.861.733371043.35500845CS
156-3.03-60.23856858855.035.861.733371043.35500845CS
260-3.03-60.23856858855.035.861.733371043.35500845CS

CLYM - Frequently Asked Questions (FAQ)

What is the current Climb Bio share price?
The current share price of Climb Bio is US$ 2.00
How many Climb Bio shares are in issue?
Climb Bio has 67,223,760 shares in issue
What is the market cap of Climb Bio?
The market capitalisation of Climb Bio is USD 125.71M
What is the 1 year trading range for Climb Bio share price?
Climb Bio has traded in the range of US$ 1.73 to US$ 5.86 during the past year
What is the PE ratio of Climb Bio?
The price to earnings ratio of Climb Bio is -9.78
What is the reporting currency for Climb Bio?
Climb Bio reports financial results in USD
What is the latest annual profit for Climb Bio?
The latest annual profit of Climb Bio is USD -35.12M
What is the registered address of Climb Bio?
The registered address for Climb Bio is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Climb Bio website address?
The website address for Climb Bio is climbbio.com
Which industry sector does Climb Bio operate in?
Climb Bio operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.69M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.83M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.31M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

Discussion

View Full Feed
ThunderousSeer8 ThunderousSeer8 42 seconds ago
Do you just come here assuming each and every person here is as destitute as you?
RDAR
Red Cloud Red Cloud 2 minutes ago
Captial Group - Growth Fund of America AGTHX

As of 9/30/24 they're showing 3,600,000 Fannie commons and a collection of Fannie and Freddie preferreds. No Freddie commons.

Should be putting up the numbers for 12/31/24 before the end of this month. I'll be interesting to
FNMA
Waynewayne Waynewayne 2 minutes ago
I’m like king where this is going!!!
HMBL
IceCold8 IceCold8 4 minutes ago
Speaks volumes on shareholders being a priority! The very segment of keeping a company active (shareholders) seems to me to be an afterthought.
CGAC
BlazingStocks BlazingStocks 4 minutes ago
$ILLR Digital Music Article January 09, 2025

Triller Pounces on TikTok Ban — Offers Video Backup for TikTok Users
https://www.digitalmusicnews.com/2025/01/09/triller-tiktok-ban-offers-video-back-up/
ILLR
delerious1 delerious1 5 minutes ago
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California
#gold #mining $NBRI
9:11 AM · Jan 10, 2025 ..... 1,720 Views

https://pbs.twimg.com/media/Gg75IJObkAAJEoz?format=jpg&name=medium
NBRI
benyam benyam 5 minutes ago
wow good dd and good work double bullish
MONI
Smartypants2 Smartypants2 6 minutes ago
Except that NEXBOARD is real...and could be exactly what people are looking for in order to live in wildfire-prone areas!
XERI
Guido2 Guido2 6 minutes ago
I believe it’s called the Capital Group. Most of its holdings in FnF commons and preferred was held by its subsidiary called American Growth Fund. They should be publishing their current holdings soon (mid-month).

Glad you’re back.

It’s good to have leaders who care ab
FNMA
12x 12x 6 minutes ago
I understand by "weaker" you mean "rapid decliner." It seems to me that dropouts can be categorized into two main types for Blarcamesine: AE-induced dropouts (AED) and rapid decline-induced dropouts (RDD).

AE-induced dropouts (AED): By intuition and comparing the baseline scores of t
AVXL
Green Leaf Smoker Green Leaf Smoker 7 minutes ago
💩💩That was then this is now as NOTHING to see here anymore current bail out SP O.OOO4 💩💩💩
MJNA
kbaz kbaz 7 minutes ago
Dis BISH Knows the Money is coming and is going after all of it.... This Ages ROBV!!!! And should..... They play a fugged up game and won't play fair........ FUGGG EM ALLLL we were with you in the tough times and believed your story. NOW you get GREEEEEDY AND LEEAVE look to leave us b
FRZT
ChannelTrader ChannelTrader 7 minutes ago
Don't bet on it...70% voted for him who lost their homes.
It’s over for Gavin
https://x.com/elonmusk/status/1877743988112777442
alertmeipp alertmeipp 8 minutes ago
Total is now 1.09mm shares - slightly over 7 percent of the public float.

If we were a fund, we would be the 5th largest holder, on par with MS. We should have a say on ENTA future direction ;)
ENTA
surfkast surfkast 8 minutes ago
That is so true. OTC scam CEO's shout verifiable good news from the proverbial mountain top!
Pumpers push Hopium and inuendo.
HMBL
hap0206 hap0206 8 minutes ago
Very informative -- they left out a key ingredient -- policies to encourage the production and use of fossil fuels vs the policies to curtail the production and use of fossil fuels -- EVs vs GP autos for example
gitreal gitreal 8 minutes ago
Softasbalsa is the new Benny....when it comes to lying, no one lies more.
AABB
meba meba 9 minutes ago
hello every one i'm new here, some leverage personn here ?? or trading crypto?
XRPUSD
Seminole Red Seminole Red 9 minutes ago
good thinking. Sam and Dave, they were real popular back then.
cjstocksup cjstocksup 10 minutes ago
2 posts below, BTW we loved Caruso, Elon backed him, and he talked about the fire dept etc.:
Coulda had Caruso
https://x.com/elonmusk/status/1878048381089563046

The EU mainstream refuses to respect democratic norms and the will of the majority. Extremely appalling!
Value_Investor Value_Investor 10 minutes ago
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the seventh, eighth, and nineth Bad news for VINC:

"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders" --- see the link below for the details.
GETY MHLD VINC
Seminole Red Seminole Red 10 minutes ago
I would rather look at Now , I cant help the past.....

Your Recent History

Delayed Upgrade Clock